An oral regimen of three direct-acting antivirals plus ribavirin taken for 12 weeks demonstrated a sustained virological response rate of 94% for people with both HIV and genotype 1 hepatitis C...
Read More
WASHINGTON — Hope and commitment motivate Deborah Persaud. An infectious disease expert, she’s among researchers worldwide who are “on a mission to find a cure for AIDS,”...
Read MoreOn behalf of the Johns Hopkins University Center for AIDS Research, we would like to express our dismay and grief at the downing of Malaysian Air flight 17 with the appalling loss of 298 innocent...
Read More
Baltimore, Maryland (July 17, 2014)— More than 1 million men and youth in sub-Saharan Africa have chosen to protect themselves and reduce their risk of contracting HIV by participating in...
Read More
Background: The potential epidemiological impact of isoniazid preventive therapy (IPT), delivered at levels that could be feasibly scaled up among people living with HIV (PLHIV) in modern,...
Read More
